Markus Rey
Impact in
-
- Pulmonary Hypertension Research and Treatments
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
-
- Blood Pressure and Hypertension Studies
- Antiplatelet Therapy and Cardiovascular Diseases
Papers in
-
- Pulmonary Hypertension Research and Treatments 7
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
-
- Antiplatelet Therapy and Cardiovascular Diseases 3
- Co-authors
- Patrick Hess (22 shared papers)Martine Clozel (13 shared papers)Marc Iglarz (7 shared papers)Changbin Qiu (3 shared papers)Oliver Nayler (10 shared papers)Magdalena Birker (9 shared papers)Thomas Weller (6 shared papers)Beat Steiner (11 shared papers)
- Journals
- Journal of Medicinal Chemistry (8 papers)Journal of Pharmacology and Experimental Therapeutics (4 papers)European Journal of Medicinal Chemistry (2 papers)Journal of Cardiovascular Pharmacology (2 papers)Pharmacology Research & Perspectives (2 papers)
- Partner nations
- SwitzerlandChinaUnited States
In The Last Decade
Markus Rey
30 papers receiving 1k citations
Peers
Comparison fields: 5 of 74
- Pulmonary and Respiratory Medicine 363
- Cardiology and Cardiovascular Medicine 157
- Physiology 19
- Organic Chemistry 118
- Pharmacology 30
Countries citing papers authored by Markus Rey
This map shows the geographic impact of Markus Rey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Rey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Rey more than expected).
Fields of papers citing papers by Markus Rey
This network shows the impact of papers produced by Markus Rey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Rey. The network helps show where Markus Rey may publish in the future.
Co-authors
The 25 scholars most cited alongside Markus Rey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 152 | |
| 2 | 2012 | 136 | |
| 3 | 2004 | 114 | |
| 4 | Bosentan, sildenafil, and their combination in the monocrotaline model of pulmonary hypertension in rats. | 2006 | 83 |
| 5 | 2006 | 75 | |
| 6 | 2017 | 50 | |
| 7 | 2019 | 49 | |
| 8 | 2015 | 48 | |
| 9 | 2015 | 45 | |
| 10 | 2014 | 41 | |
| 11 | 2015 | 34 | |
| 12 | 2017 | 27 | |
| 13 | 2017 | 26 | |
| 14 | 2007 | 22 | |
| 15 | 2013 | 22 | |
| 16 | 2016 | 20 | |
| 17 | 2013 | 19 | |
| 18 | Simultaneous pulmonary and systemic blood pressure and ECG Interval measurement in conscious, freely moving rats. | 2012 | 18 |
| 19 | 2013 | 16 | |
| 20 | 2013 | 14 |
About Markus Rey
Markus Rey is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine, Molecular Biology, Organic Chemistry and Psychiatry and Mental health, having authored 31 papers that have together received 1.1k indexed citations. Recurring topics across this work include Sphingolipid Metabolism and Signaling (9 papers), Pulmonary Hypertension Research and Treatments (7 papers), Synthesis and biological activity (5 papers), Ion channel regulation and function (4 papers), Epilepsy research and treatment (3 papers), Nitric Oxide and Endothelin Effects (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (363 citations), Cardiology and Cardiovascular Medicine (157 citations), Physiology (19 citations), Organic Chemistry (118 citations) and Pharmacology (30 citations). Markus Rey has collaborated with scholars based in Switzerland, China and United States. Frequent co-authors include Patrick Hess, Martine Clozel, Marc Iglarz, Changbin Qiu, Oliver Nayler, Magdalena Birker, Thomas Weller, Beat Steiner, Martin H. Bolli and Walter Fischli. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics, European Journal of Medicinal Chemistry, Journal of Cardiovascular Pharmacology and Pharmacology Research & Perspectives.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.